| Material identity | Urolithin A; CAS 1143-70-0; molecular formula C13H8O4; molecular weight approximately 228.20 g/mol | Batch-specific certificate of analysis, LC-MS or equivalent identity data, and a clear product specification | Confirms that the supplied compound matches the declared chemical identity and is not an incorrectly labeled related compound. |
| Assay and purity | A practical purchasing benchmark is ≥98.0% assay by a validated chromatographic method; the acceptance limit should be agreed in the specification before ordering. | HPLC or UPLC chromatogram, method summary, reference standard information, and batch-specific assay result | High assay alone does not prove identity, but it helps control the level of related substances and manufacturing consistency. |
| Related substances | Defined limits for specified and unspecified impurities, with a total impurity limit stated in the product specification | Full chromatographic impurity profile rather than an assay-only report | A transparent impurity profile provides a better indication of process control and batch quality. |
| Analytical method quality | The method should be documented and suitable for its intended purpose, with evidence of specificity, precision, accuracy, linearity, and system suitability where applicable. | Method validation or verification summary and representative chromatograms | A numerical result is meaningful only when it is generated by a controlled and appropriate analytical method. |
| Residual solvents | Each detected solvent should comply with the applicable limits in ICH Q3C or the destination-market requirement. | Batch-specific GC test report listing solvents tested, limits, and results | Organic solvents may remain after synthesis or purification and require controlled limits. |
| Elemental impurities | Results should be assessed against the applicable permitted daily exposure limits in ICH Q3D, taking the intended dosage into account. | ICP-MS or ICP-OES report covering relevant elements such as lead, cadmium, mercury, and arsenic | Metal contamination can originate from raw materials, catalysts, water, or processing equipment. |
| Microbiological quality | Limits should be defined according to the product form, intended use, and applicable pharmacopoeial or market requirements. | Total aerobic microbial count, total yeast and mold count, and specified microorganism testing where applicable | Microbiological controls are particularly important when the powder will be used in dietary supplements or other ingestible products. |
| Manufacturing system | Documented quality management procedures, controlled production records, deviation handling, change control, and corrective and preventive action procedures | Quality manual, audit questionnaire, manufacturing flow chart, and relevant certification or inspection evidence | A reliable quality system supports repeatable production and traceable responses to quality issues. |
| Batch traceability | Every container should be linked to a unique batch number, production date, retest or expiry date, and complete manufacturing records. | Sample label, batch record excerpt, certificate of analysis, and traceability procedure | Traceability enables targeted investigations, recalls, and verification of supplied material. |
| Stability and shelf life | Shelf-life claims should be supported by real-time and, where appropriate, accelerated stability data under defined temperature and humidity conditions. | Stability protocol, time-point results, storage conditions, and packaging configuration | Urolithin A quality may be affected by moisture, light, oxygen, and temperature during storage. |
| Packaging and storage | Use sealed, food- or pharmaceutical-suitable inner packaging with protection from moisture and light; storage instructions must be stated on the label. | Packaging specification, product label, recommended storage conditions, and transport protection details | Appropriate packaging helps preserve assay, appearance, and physical properties throughout shipment and storage. |
| Solubility and physical properties | The specification should state appearance, color, particle-size information where relevant, bulk density if needed, and a standardized solubility or dispersion method. | Physical-property specification and a representative sample for independent testing | Consistent physical properties are important for formulation, blending, encapsulation, and filling operations. |
| Pre-shipment sample approval | Approve a representative sample and written specification before placing a commercial bulk order. | Sealed sample, sample test report, and signed quality agreement or specification sheet | Sample approval reduces the risk of receiving material that differs from the originally evaluated product. |
| Independent verification | Use an independent, competent laboratory for identity, assay, impurities, residual solvents, and contaminants before approving the first bulk shipment. | Third-party test report linked to the exact batch number and sealed sample | Independent testing provides an objective check of the supplier’s certificate of analysis. |
| Commercial reliability | Evaluate documented production capacity, minimum order quantity, lead time, lot availability, export experience, and written handling of out-of-specification results. | Quotation, production schedule, quality agreement, complaint procedure, and replacement or refund terms | Commercial transparency helps prevent supply interruptions and disputes after purchase. |